FTC cows Sanofi into giving up on Maze licensing deal
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.
Stay updated with breaking news from Bruce Booth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.
Massachusetts biomanufacturing workforce had a year-over-year growth of 6.3%, outpacing New York and California, says MassBio 2023 Industry Snapshot.
Massachusetts biomanufacturing workforce had a year-over-year growth of 6.3%, outpacing New York and California, says MassBio 2023 Industry Snapshot.
Billions of dollars is poured into mining in remote Australia, so why don't the lights stay on in nearby communities?
Current CFO Erik Ostrowski named interim CEO, replacing Founding President and CEO Geoff MacKay ... | May 1, 2023